AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 6 | -90.8% | 0.00% | – |
| Q4 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |